Eleven Biotherapeutics Inc. (EBIO) Shares Up 7.1%
Eleven Biotherapeutics Inc. (NASDAQ:EBIO)’s share price shot up 7.1% on Wednesday . The stock traded as high as $4.09 and last traded at $3.93, with a volume of 1,683,893 shares trading hands. The stock had previously closed at $3.67.
The firm’s 50-day moving average is $2.67 and its 200-day moving average is $1.21. The stock’s market capitalization is $60.19 million.
In other Eleven Biotherapeutics news, major shareholder Boxer Capital, Llc sold 1,042,000 shares of the business’s stock in a transaction dated Monday, June 13th. The stock was sold at an average price of $2.74, for a total transaction of $2,855,080.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Eleven Biotherapeutics, Inc is a clinical-stage biopharmaceutical company. The Company through AMP-Rx, a protein engineering platform, is engaged in the discovery and development of protein therapeutics to treat diseases of the eye. The Company designs, engineers and generates a pipeline of protein therapeutic candidates that target cytokines, which are central to diseases of the eye.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.